International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 4

United States | Computer Science and Information Technology | Volume 14 Issue 3, March 2025 | Pages: 73 - 78


The Impact of Pega on Oncology: Streamlining Workflows, Accelerating Clinical Trials, and Improving Patient Care

Sairohith Thummarakoti

Abstract: Advanced technology is required in cancer care and research to handle the complex workflow, large dataset, and real-time decision-making that is in high demand. Pega's platform helps integrate oncology workflows and automates processes, providing advanced data analytics that are domain-focused for healthcare. It also ensures easy integration with systems such as GRAIL's Galleri test and real-time data analytics powered by Apache Kafka, making health care providers and researchers empowered with actionable insights. This paper highlights the efficiency difference, automation, and domain-specific capabilities that Pega has over other platforms, which clearly show the high return on investment and transformative impact on oncology care. Pega accelerates precision medicine and value-based care models by optimized patient management, acceleration of clinical trials, and interdisciplinary collaboration and sets new standards in fighting against cancer.

Keywords: Oncology, Pega, Workflow Integration, Data Analytics, Precision Medicine, Clinical Trials, Automation, Patient Care, Healthcare Technology, Cancer Research

How to Cite?: Sairohith Thummarakoti, "The Impact of Pega on Oncology: Streamlining Workflows, Accelerating Clinical Trials, and Improving Patient Care", Volume 14 Issue 3, March 2025, International Journal of Science and Research (IJSR), Pages: 73-78, https://www.ijsr.net/getabstract.php?paperid=SR25208073453, DOI: https://dx.doi.org/10.21275/SR25208073453


Download Article PDF


Rate This Article!

Received Comments

No approved comments available.


Top